Q1 2025 Hillenbrand Inc Earnings Call Transcript
Key Points
- Hillenbrand Inc (HI) announced the sale of a 51% stake in its Milacron injection molding and extrusion business to Bain Capital, which is expected to enhance shareholder value and focus on core business growth.
- The company reported strong order performance within its food, health, and nutrition portfolio, indicating robust demand in these sectors.
- Hillenbrand Inc (HI) achieved record aftermarket orders in its Advanced Process Solutions (APS) segment, highlighting the strength of its value-added services.
- The company is on track to achieve its $30 million run rate cost synergy target by the end of the fiscal year, ahead of the initial timeline.
- Hillenbrand Inc (HI) is making significant strides in cross-selling opportunities, which is expected to accelerate as market conditions improve.
- Consolidated revenue for the quarter was down 9% year-over-year, reflecting lower starting backlog and reduced capital equipment demand.
- Adjusted earnings per share decreased by 19% compared to the previous year, impacted by lower volume and cost inflation.
- The company continues to face uncertainty around inflation, interest rates, and government policy, affecting customer order decisions.
- The MTS segment experienced ongoing market slowness, particularly in North America and Europe, with softness in the automotive sector.
- Hillenbrand Inc (HI) anticipates a modest increase in leverage in Q2 before reducing it by the end of the fiscal year, indicating ongoing financial pressure.
Greetings and welcome to the Hillenbrand first quarter and full year 2025 earnings call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone should require operator assistance, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce Sam Mynsberge Vice President, Investor Relations. Thank you. You may begin.
Thank you, operator and good morning, everyone. Welcome to Hillenbrand's conference call where we will be discussing our fiscal first quarter performance as well as the sale of a majority stake in our Milacron injection molding and extrusion business within the molding technology solutions or MTF segment that we announced in an eight K and our earnings release yesterday afternoon.
I'm joined by our President and CEO Kim Ryan and our Senior Vice President and CFO Bob VanHimbergen.
I'd like to direct your attention to the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
